全球動物模型市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

全球動物模型市場預計將從2025年的31億美元成長至2034年的71.5億美元，2026年至2034年的複合年成長率（CAGR）為9.73%。全球動物模型市場持續成長，主要得益於藥物研發、疾病研究和生物技術領域研究的不斷深入。動物模型在臨床前試驗和闡明複雜生物學過程方面發揮著至關重要的作用。製藥業研發投入的增加以及慢性病盛行率的上升，正顯著推動市場擴張。

推動這一成長的因素包括基因工程的進步、對個人化醫療日益成長的需求以及生物醫學研究的擴展。基因改造和人源化動物模型的開發提高了研究的準確性和效率。政府和學術界對生命科學研究的資助也進一步促進了市場成長。

預計未來該市場將持續成長，這主要得益於生物技術和精準醫療領域的創新。倫理考量和法律規範將繼續影響研究實踐。諸如「晶片器官」技術等新型替代方法將在短期內作為動物模型的補充，而不是完全取代它們。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球動物模型市場：依應用範圍分類

• 市場分析、洞察與預測
• 癌症
• 免疫疾病
• 感染疾病
• 其他

第5章：全球動物模型市場：依動物類型分類

• 市場分析、洞察與預測
• 老鼠
• 鼠
• 天竺鼠
• 兔子
• 倉鼠
• 其他

第6章：全球動物模型市場：依最終用途分類

• 市場分析、洞察與預測
• 製藥和生物技術公司
• 學術研究機構
• 合約研究組織（CRO）

第7章：全球動物模型市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Biocytogen Pharma
  • Charles River Laboratories International Inc
  • CLEA JapanInc
  • Cyagen Biosciences
  • GemPharmatech
  • GenOway
  • Harbour BioMed
  • Hera BioLabs
  • Ingenious Targeting Laboratory
  • Innovative Research
  • InotivInc
  • Janvier Labs
  • JSR Corporation（Crown Bioscience）
  • Ozgene Pty Ltd
  • PolyGene AG
  • Shanghai Model Organisms CenterInc
  • Taconic BiosciencesInc
  • The Jackson Laboratory
  • Trans Genic Inc

The global animal model market size is expected to reach USD 7.15 Billion in 2034 from USD 3.10 Billion in 2025, growing at a CAGR of 9.73 during 2026-2034.The Global Animal Model Market has witnessed steady growth due to increasing research in drug development, disease studies, and biotechnology. Animal models play a critical role in preclinical testing and understanding complex biological processes. Rising investments in pharmaceutical R&D and the growing prevalence of chronic diseases have significantly supported market expansion.

Growth drivers include advancements in genetic engineering, increasing demand for personalized medicine, and expanding biomedical research initiatives. The development of transgenic and humanized animal models has enhanced research accuracy and efficiency. Government and academic funding for life sciences research further strengthens market growth.

In the future, the market is expected to grow alongside innovation in biotechnology and precision medicine. Ethical considerations and regulatory frameworks will continue shaping research practices. Emerging alternatives such as organ-on-chip technologies may complement, but not fully replace, animal models in the near term.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Application Scope

• Cancer
• Immunological Disease
• Infectious Disease
• Others

By Animal Type

• Mice
• Rat
• Guinea Pigs
• Rabbits
• Hamsters
• Others

By End-use

• Pharmaceutical & Biotechnology Companies
• Academic Research Institute
• Contract Research Organization

COMPANIES PROFILED

• Biocytogen Pharma, Charles River Laboratories International Inc., CLEA Japan, Inc., Cyagen Biosciences, GemPharmatech, genOway, Harbour BioMed, Hera BioLabs, Ingenious Targeting Laboratory, Innovative Research, Inotiv, Inc., Janvier Labs, JSR Corporation (Crown Bioscience), Ozgene Pty Ltd, PolyGene AG, Shanghai Model Organisms Center, Inc., Taconic Biosciences, Inc., The Jackson Laboratory, Trans Genic Inc.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ANIMAL MODEL MARKET: BY APPLICATION SCOPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Application Scope
• 4.2. Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Immunological Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Infectious Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ANIMAL MODEL MARKET: BY ANIMAL TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Animal Type
• 5.2. Mice Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Rat Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Guinea Pigs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Rabbits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Hamsters Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ANIMAL MODEL MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Academic Research Institute Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Contract Research Organization Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ANIMAL MODEL MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Application Scope
  • 7.2.2 By Animal Type
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Application Scope
  • 7.3.2 By Animal Type
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Application Scope
  • 7.4.2 By Animal Type
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Application Scope
  • 7.5.2 By Animal Type
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Application Scope
  • 7.6.2 By Animal Type
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ANIMAL MODEL INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Biocytogen Pharma
  • 9.2.2 Charles River Laboratories International Inc
  • 9.2.3 CLEA JapanInc
  • 9.2.4 Cyagen Biosciences
  • 9.2.5 GemPharmatech
  • 9.2.6 GenOway
  • 9.2.7 Harbour BioMed
  • 9.2.8 Hera BioLabs
  • 9.2.9 Ingenious Targeting Laboratory
  • 9.2.10 Innovative Research
  • 9.2.11 InotivInc
  • 9.2.12 Janvier Labs
  • 9.2.13 JSR Corporation (Crown Bioscience)
  • 9.2.14 Ozgene Pty Ltd
  • 9.2.15 PolyGene AG
  • 9.2.16 Shanghai Model Organisms CenterInc
  • 9.2.17 Taconic BiosciencesInc
  • 9.2.18 The Jackson Laboratory
  • 9.2.19 Trans Genic Inc